In vitro competition binding research verified that MAM-2201 and AM-2201 possess nanomolar affinity for each CD-1 murine and human CB1 and CB2 receptors, with choice for your CB1 receptor. In settlement While using the in vitro binding data, in vivo experiments showed that MAM-2201 induces visual, acoustic, and tactile impairments https://nicky838izo1.magicianwiki.com/user